<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02643875</url>
  </required_header>
  <id_info>
    <org_study_id>HSEARS20151002004</org_study_id>
    <nct_id>NCT02643875</nct_id>
  </id_info>
  <brief_title>Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters</brief_title>
  <official_title>Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Menicon Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queensland University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <brief_summary>
    <textblock>
      Orthokeratology (ortho-k) is a clinical technique that uses reverse geometry rigid gas
      permeable contact lens exerting positive pressure on the central cornea to temporary reduce
      refractive error. The investigators have shown that this treatment is effective for myopic
      control in low to high myopes, with and without astigmatism. Most designs of ortho-k lenses
      in the market are fitted based on the Jessen formula. The compression factor was introduced
      to compensate for regression of the ortho-k effect during the no lens-wear period, so that
      the wearer can obtain clear distance vision throughout the day and most lens designs use a
      compression factor of 0.50-0.75D. However, in a retrospective study (mixed brands of ortho-k
      lenses), showed that most patients did not achieve an over-correction of 0.75D. In order to
      achieve an over-correction of 0.75D, an extra flattening power of about 1.50D instead of
      0.75D should be be targeted. The increased compression factor is expected to increase the
      target reduction and it may play a role in myopic control and providing a higher successful
      rate in fitting ortho-k lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 26, 2016</start_date>
  <completion_date type="Actual">November 18, 2016</completion_date>
  <primary_completion_date type="Actual">November 18, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of myopic reduction</measure>
    <time_frame>7 days</time_frame>
    <description>Refractive error</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal integrity</measure>
    <time_frame>7 days</time_frame>
    <description>Corneal integrity will be assessed by slit lamp microscopy with reference to Efron grading scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short term choroidal thickness</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short term change in ocular aberration</measure>
    <time_frame>7 days</time_frame>
    <description>Ocular aberration will be measured by using the complete ophthalmic analysis system aberrometer (COAS, Wavefront Sciences Inc.).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Myopic Progression</condition>
  <arm_group>
    <arm_group_label>Ortho-k lens with normal compression factor</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The eye wears ortho-k lens with normal compression factor to achieve plano (+/- 0.25D) correction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ortho-k lenses with increased compression factor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The eye wears ortho-k lenses with increased compression factor to achieve 1 diopter (+/- 0.25D) over correction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orthokeratology</intervention_name>
    <description>It is a kind of rigid permeable lens.</description>
    <arm_group_label>Ortho-k lens with normal compression factor</arm_group_label>
    <arm_group_label>Ortho-k lenses with increased compression factor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 6 to 10 years old

          2. Myopia: between 0.50 D and 4.00 D in both eyes

          3. Astigmatism: &lt;1.50 D; ≤ 1.25 D for with-the-rule astigmatism (axes 180 ± 30); ≤ 0.50 D
             for astigmatism of other axes in both eyes

          4. Anisometropia: ≤ 1.50 D

          5. Symmetrical corneal topography with corneal toricity &lt;2.00 D in both eyes

          6. Agree for randomization

        Exclusion Criteria:

          1. Contraindications for orthokeratology wear (e.g. limbus-to-limbus corneal cylinder and
             dislocated corneal apex)

          2. Any type of strabismus or amblyopia

          3. Myopic treatment (e.g. refractive surgery and progressive lens wear for myopic
             control) before and during the study period

          4. Rigid contact lenses (including orthokeratology lenses) experience

          5. Systemic condition which might affect refractive development (for example, Down
             syndrome, Marfan's syndrome)

          6. Ocular conditions which might affect the refractive error (for example, cataract,
             ptosis)

          7. Poor compliance for lens wear or follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pauline Cho, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hong Kong Polytechnic University</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005 Jan;30(1):71-80.</citation>
    <PMID>15875367</PMID>
  </reference>
  <reference>
    <citation>Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85. doi: 10.1167/iovs.12-10565.</citation>
    <PMID>22969068</PMID>
  </reference>
  <reference>
    <citation>Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013 Oct 3;54(10):6510-7. doi: 10.1167/iovs.13-12527.</citation>
    <PMID>24003088</PMID>
  </reference>
  <reference>
    <citation>Chan B, Cho P, Mountford J. The validity of the Jessen formula in overnight orthokeratology: a retrospective study. Ophthalmic Physiol Opt. 2008 May;28(3):265-8. doi: 10.1111/j.1475-1313.2008.00545.x.</citation>
    <PMID>18426426</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>December 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2015</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Pauline Cho</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>myopia control</keyword>
  <keyword>orthokeratology</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

